321 related articles for article (PubMed ID: 29460465)
1. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of volumetric modulated arc therapy patient specific QA results to multileaf collimator errors and correlation to dose volume histogram based metrics.
Coleman L; Skourou C
Med Phys; 2013 Nov; 40(11):111715. PubMed ID: 24320423
[TBL] [Abstract][Full Text] [Related]
3. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
[TBL] [Abstract][Full Text] [Related]
4. IMRT QA and gamma comparisons: The impact of detector geometry, spatial sampling, and delivery technique on gamma comparison sensitivity.
Steers JM; Fraass BA
Med Phys; 2021 Sep; 48(9):5367-5381. PubMed ID: 34036596
[TBL] [Abstract][Full Text] [Related]
5. Comparisons of volumetric modulated arc therapy (VMAT) quality assurance (QA) systems: sensitivity analysis to machine errors.
Liang B; Liu B; Zhou F; Yin FF; Wu Q
Radiat Oncol; 2016 Nov; 11(1):146. PubMed ID: 27821135
[TBL] [Abstract][Full Text] [Related]
6. Initial clinical experience with ArcCHECK for IMRT/VMAT QA.
Aristophanous M; Suh Y; Chi PC; Whittlesey LJ; LaNeave S; Martel MK
J Appl Clin Med Phys; 2016 Sep; 17(5):20-33. PubMed ID: 27685107
[TBL] [Abstract][Full Text] [Related]
7. Investigation of error detection capabilities of phantom, EPID and MLC log file based IMRT QA methods.
Defoor DL; Stathakis S; Roring JE; Kirby NA; Mavroidis P; Obeidat M; Papanikolaou N
J Appl Clin Med Phys; 2017 Jul; 18(4):172-179. PubMed ID: 28585300
[TBL] [Abstract][Full Text] [Related]
8. Determination of MLC model parameters for Monaco using commercial diode arrays.
Kinsella P; Shields L; McCavana P; McClean B; Langan B
J Appl Clin Med Phys; 2016 Jul; 17(4):37-47. PubMed ID: 27455495
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems.
Hussein M; Rowshanfarzad P; Ebert MA; Nisbet A; Clark CH
Radiother Oncol; 2013 Dec; 109(3):370-6. PubMed ID: 24100148
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pretreatment VMAT quality assurance with the integral quality monitor (IQM) and electronic portal imaging device (EPID).
Ghafarian M; Price M; Morales-Paliza M
J Appl Clin Med Phys; 2021 Mar; 22(3):166-175. PubMed ID: 33596336
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT.
Kim JI; Park SY; Kim HJ; Kim JH; Ye SJ; Park JM
Radiat Oncol; 2014 Jul; 9():167. PubMed ID: 25070065
[TBL] [Abstract][Full Text] [Related]
12. Incorrect dosimetric leaf separation in IMRT and VMAT treatment planning: Clinical impact and correlation with pretreatment quality assurance.
Sjölin M; Edmund JM
Phys Med; 2016 Jul; 32(7):918-25. PubMed ID: 27394690
[TBL] [Abstract][Full Text] [Related]
13. Comparison of MLC error sensitivity of various commercial devices for VMAT pre-treatment quality assurance.
Saito M; Sano N; Shibata Y; Kuriyama K; Komiyama T; Marino K; Aoki S; Ashizawa K; Yoshizawa K; Onishi H
J Appl Clin Med Phys; 2018 May; 19(3):87-93. PubMed ID: 29500857
[TBL] [Abstract][Full Text] [Related]
14. Individual volume-based 3D gamma indices for pretreatment VMAT QA.
Yi J; Han C; Zheng X; Zhou Y; Deng Z; Xie C; Jin X; Jin F
J Appl Clin Med Phys; 2017 May; 18(3):28-36. PubMed ID: 28318101
[TBL] [Abstract][Full Text] [Related]
15. Composite QA for intensity-modulated radiation therapy using individual volume-based 3D gamma indices.
Han C; Yu W; Zheng X; Zhou Y; Gong C; Xie C; Jin X
J Radiat Res; 2018 Sep; 59(5):669-676. PubMed ID: 30085157
[TBL] [Abstract][Full Text] [Related]
16. Reliability of the gamma index analysis as a verification method of volumetric modulated arc therapy plans.
Park JM; Kim JI; Park SY; Oh DH; Kim ST
Radiat Oncol; 2018 Sep; 13(1):175. PubMed ID: 30217163
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
[TBL] [Abstract][Full Text] [Related]
18. A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry : A step to QA with in vivo EPID dosimetry.
Moustakis C; Ebrahimi Tazehmahalleh F; Elsayad K; Fezeu F; Scobioala S
Strahlenther Onkol; 2020 Feb; 196(2):182-192. PubMed ID: 31925465
[TBL] [Abstract][Full Text] [Related]
19. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
Zhen H; Nelms BE; Tome WA
Med Phys; 2011 Oct; 38(10):5477-89. PubMed ID: 21992366
[TBL] [Abstract][Full Text] [Related]
20. IMRT QA: Selecting gamma criteria based on error detection sensitivity.
Steers JM; Fraass BA
Med Phys; 2016 Apr; 43(4):1982. PubMed ID: 27036593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
